The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
Business Of Biotech
00:00
CDMO Selection Is the Most Critical Crucial Decision That Companies Are Making Right Now
Audrey: I completely am aligned with the mission driven aspect of our business. CDMO selection is the most critical crucial decision that companies are making right now. Starting early having a reliable process, having safety and a robust GMP manufacturing environment is all what needs to be taking into consideration. And then just close out this thought and open technique questions you have is really the ability to reduce upfront capital expenses at these resource can trains.
Transcript
Play full episode
